Identification, Electro-mechanical Characterisation and Ablation of Driver Regions in Persistent Atrial Fibrillation
2 other identifiers
observational
30
1 country
1
Brief Summary
Atrial fibrillation (AF) is the most common sustained heart rhythm abnormality. Its incidence is increasing partly due to the aging population and it has been referred to as a growing epidemic. AF results in irregular contractions of the heart causing unpleasant symptoms of palpitations and increasing the risk of stroke, heart failure and death. Percutaneous catheter ablation is a safe treatment option in symptomatic patients with AF. The success rate of these procedures have improved with time due to our better understanding of AF, development of new techniques and technology, and greater physician experience. However, the success rate of these procedures still only remains around 70%. This is secondary to our limited ability to find the areas that drive AF. STAR mapping is a novel mapping system that has been developed with a view of better identifying the sites that drive AF through taking into account the mechanisms of AF we have so far demonstrated. To validate this mapping system we aim to use it in patients with atrial tachycardia (AT), which is a heart rhythm abnormality of which the mechanism can be readily identified with the existing mapping systems used in clinical practice. We will demonstrate that the STAR mapping algorithm can effectively map AT.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2016
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2016
CompletedFirst Submitted
Initial submission to the registry
January 17, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2019
CompletedFirst Posted
Study publicly available on registry
March 28, 2024
CompletedMarch 28, 2024
March 1, 2024
3 years
January 17, 2018
March 21, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
STAR maps compared to conventional maps
The STAR maps demonstrating the source of the AT correlate with the maps created by the conventional mapping system.
At procedure
Study Arms (1)
Atrial tachycardia- validation phase
The group will consist of patients with AT (whether de novo or occurring post AF ablation) that are undergoing catheter ablation.
Interventions
Signals will be collected during the catheter ablation. These signals STAR maps will be created post procedure and these will be compared to the conventional maps used during the atrial tachycardia ablation. This will be used to validate the STAR maps created.
Eligibility Criteria
Patients with AT (whether de novo or occurring post AF ablation) undergoing catheter ablation.
You may qualify if:
- Patients able to provide informed consent
- Patients with AT (whether de novo or occurring post AF ablation)
You may not qualify if:
- Unwillingness to sign consent
- Age \<18 years old
- Contraindications for catheter ablation procedure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Barts Heart Centre
London, EC1A 7BE, United Kingdom
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 17, 2018
First Posted
March 28, 2024
Study Start
October 1, 2016
Primary Completion
October 1, 2019
Study Completion
October 1, 2019
Last Updated
March 28, 2024
Record last verified: 2024-03